LACTOSE (INDIA) LTD. Share Price

LACTOSE (INDIA) LTD. Share Price

BSE: 524202
|
Pharmaceuticals
|
S Cap
₹ 98.60
-₹4.85 (-4.69%)
1D
Last updated 23 Sep, 2026, 09:53 IST

LACTOSE (INDIA) LTD. Share Price Today

As of 23 Sep 2026, LACTOSE (INDIA) LTD. share price is ₹98.60. The stock opened at ₹103.95, compared to its previous close of ₹103.45. During today's trading session, LACTOSE (INDIA) LTD. share price moved in the range of ₹98.60 to ₹103.95, with an average price of ₹101.28 for the day. Looking at its last 52-week, the stock has touched a low of ₹76.01 and a high of ₹136.45.

₹98.60
4.69% down today
₹103.95
1D LOW
1D HIGH

LACTOSE (INDIA) LTD. Returns Calculator

Circuit
L
H
₹82.80
₹124.10
52-week
L
H
₹76.01
₹136.45

About LACTOSE (INDIA) LTD.

LACTOSE (INDIA) LTD. Share Price
ISIN
INE058I01013
Sector Market Cap
₹ 130.23 Cr

Lactose (India) Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It specializes in manufacturing of lactose monohydrate IP/BP/EP/USP-NF grades. The Company’s lactose products include Formulac 200M, Formulac 80M, Formulac 100M, Formulac 325M, Formulac DC60, Formulac 450M, Formulac 314M and Formulac DC2050. It is also engaged in the manufacturing of disaccharide lactulose, a versatile bulk API. Disaccharide Lactulose (galacto-fructose) is synthesized from lactose (galacto-glucose) by isomerization of glucose to fructose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic.

LACTOSE (INDIA) LTD. Financial Highlights

  • Revenue: LACTOSE (INDIA) LTD. reported revenue of ₹164.36 crore in FY26 vs ₹117.85 crore in FY25. It showed an increase of 39.47% on a yearly basis.
  • Operating Profit: LACTOSE (INDIA) LTD. reported an operating profit of ₹8.62 crore in FY26 vs ₹6.92 crore in FY25. It showed an increase of 24.57% on a year-on-year basis.
  • Net Profit: LACTOSE (INDIA) LTD. reported a net profit of ₹6.06 crore in FY26 vs ₹5.16 crore in FY25. It showed an increase of 17.44% on a yearly basis.

LACTOSE (INDIA) LTD. Quarterly Result Highlights

  • LACTOSE (INDIA) LTD. reported revenue of ₹47.53 crore in Jun 2026, compared with ₹45.99 crore in Mar 2026, representing an increase of 3.35% on a quarter-on-quarter (QoQ) basis.
  • LACTOSE (INDIA) LTD. reported an operating profit of ₹3.23 crore in Jun 2026, compared with ₹2.31 crore in Mar 2026, representing an increase of 39.83% on a quarter-on-quarter (QoQ) basis.
  • LACTOSE (INDIA) LTD. reported a profit of ₹2.37 crore in Jun 2026, compared with ₹1.88 crore in Mar 2026, reflecting an increase of 26.06% on a QoQ basis.
  • The earnings per share (EPS) of LACTOSE (INDIA) LTD. stood at ₹4.10 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
53.65%
FII
0.00%
Other DII
0.62%
Retail and other
45.74%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
130.23
P/E
18.81
P/B
2.24
ROE
9.36%
D/E
0.96
ROCE
10.75%
Div. Yield
0.00%
EPS(TTM)
4.82
Turnover
0.93
EV/EBITDA
8.90
Net Margin
3.71%
Op. Margin
11.91%
ROA
3.79%
Quick Ratio
0.48
Curr. Ratio
1.95
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Lactose (India) outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Lactose (India) appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

LACTOSE (INDIA) LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹116.40₹113.89₹65.80₹45.94
Other Income₹1.45₹1.12₹0.72₹0.58
Total Revenue₹117.85₹115.01₹66.52₹46.52
Total Expenses₹110.94₹105.35₹65.05₹43.35
Profit Before Tax₹6.92₹9.66₹1.46₹3.17
Tax₹1.75₹2.88₹0.26₹0.72
Profit After Tax₹5.16₹6.79₹1.21₹2.45
EPS - Basic₹4.10₹5.39₹0.96₹2.10
EPS - Diluted₹4.10₹5.39₹0.96₹2.10

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹8.62₹6.92₹9.66₹1.46
Income before WC changes₹18.33₹17.26₹19.60₹12.07
Change in Assets-₹48.35-₹19.35-₹0.14-₹16.82
Change in Liabilities₹36.76₹2.93-₹9.95₹12.68
Change in WC-₹11.60-₹16.42-₹10.08-₹4.13
Cash flow from Operations₹5.56-₹0.29₹8.75₹7.89
Cash flow from Investing-₹10.22-₹15.57-₹2.08-₹0.92
Cash flow from Financing₹0.71₹18.81-₹5.72-₹8.32
Total Cash Flow-₹3.95₹2.95₹0.95-₹1.34
Cash (Start of the year)₹4.48₹1.53₹0.58₹1.92
Cash (End of the year)₹0.53₹4.48₹1.53₹0.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹76.14₹65.21₹63.89₹67.47
Current Assets₹57.33₹35.53₹37.40₹22.75
Total Assets₹133.47₹100.74₹101.29₹90.22
Current Liabilities₹44.89₹25.40₹26.47₹14.91
Net Current Asset₹12.44₹10.13₹10.93₹7.84
Non-Current Liabilities₹29.84₹28.24₹34.26₹36.03
Equity Capital₹58.74₹47.10₹40.56₹39.28
Total Equity & Liabilities₹133.47₹100.74₹101.29₹90.22
* All values are in INR Crore
Qty
Bid
32
100
100
99.9
100
99.8
100
99.7
101
99.6
Ask
Qty
102.2
35
102.25
500
102.3
12
102.95
14
103.7
44
Bid Total: 433
Ask Total: 605
Buy orders: 42%
Sell orders: 58%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
52.83
Neutral
ATR (14)
4.67
Neutral
STOCH(9,6)
81.51
Bearish
STOCH RSI (14)
81.63
Bearish
ADX(9)
14.54
Bullish
UO(9)
60.36
Neutral
ROC(12)
2.22
Bullish
WillR(14)
-51.63
Neutral
Period
Simple value
Exponential vaue
5D
101.19
101.67
10D
100.73
101.53
20D
102.31
101.86
50D
102.41
102.68
100D
106.06
102.98
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
LACTOSE (INDIA) LTD. Share Price
LACTOSE (INDIA) LTD.
Pharmaceuticals
Add Stock
Add Another

LACTOSE (INDIA) LTD. Share Price FAQs

LACTOSE (INDIA) LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837